Application
BTF3 Antibody (N-term) western blot analysis in A549 cell line lysates (35ug/lane).This demonstrates the BTF3 antibody detected the BTF3 protein (arrow).Application
BTF3 Antibody (N-term) western blot analysis in mouse bladder tissue lysates (35ug/lane).This demonstrates the BTF3 antibody detected the BTF3 protein (arrow).| Product Name | BTF3 Antibody (N-term) |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | BTF3; NACB; Transcription factor BTF3; RNA polymerase B transcription factor 3 |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WB |
| WB:1:100~500 |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Gene Synonyms | NACB |
|---|---|
| Alternative Names | BTF3 NACB Transcription factor BTF3 RNA polymerase B transcription factor 3 |
| Molecular Weight(MW) | 22168 Da |
| Function | General transcription factor. BTF3 can form a stable complex with RNA polymerase II. Required for the initiation of transcription |
| Tissue Specificity | This BTF3 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 1-30 amino acids from the N-terminal region of human BTF3. |
| Cellular Localization | Nucleus. |
| Entrez Gene | 689 |
|---|---|
| Nucleotide Accession | NP_001198.2 NP_001032726.1 |
Application
BTF3 Antibody (N-term) western blot analysis in A549 cell line lysates (35ug/lane).This demonstrates the BTF3 antibody detected the BTF3 protein (arrow).
Application
BTF3 Antibody (N-term) western blot analysis in mouse bladder tissue lysates (35ug/lane).This demonstrates the BTF3 antibody detected the BTF3 protein (arrow).| Application Notes | WB:1:100~500 |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
